Cargando…
Development of a Personalised Device for Systemic Magnetic Drug Targeting to Brain Tumours
Delivering therapies to deeply seated brain tumours (BT) is a major clinical challenge. Magnetic drug targeting (MDT) could overcome this by rapidly transporting magnetised drugs directly into BT. We have developed a magnetic device for application in murine BT models using an array of neodymium mag...
Autores principales: | Patel, Priya, Alghamdi, Areej, Shaw, Gary, Legge, Christopher, Glover, Maggie, Freeman, Danielle, Hodgetts, Harry, Wilson, Erica, Howard, Faith, Staniland, Sarah, Kennerley, Aneurin J, Wood, Duncan, Moorehead, Robert, Hadfield, Charlotte, Rominiyi, Ola, Griffin, Jon, Collis, Spencer J, Hyde, Sam, Crossley, Marcus, Paley, Martyn, Muthana, Munitta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760367/ https://www.ncbi.nlm.nih.gov/pubmed/36593801 http://dx.doi.org/10.7150/ntno.76559 |
Ejemplares similares
-
Magnetosomes and Magnetosome Mimics: Preparation, Cancer Cell Uptake and Functionalization for Future Cancer Therapies
por: Taher, Zainab, et al.
Publicado: (2021) -
Use of magnetic resonance targeting to steer ov-loaded cell-based therapies to tumor sites in vivo
por: Muthana, Munitta, et al.
Publicado: (2015) -
DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies
por: Rominiyi, Ola, et al.
Publicado: (2021) -
Inconsistencies in Modeling the Efficacy of the Oncolytic Virus HSV1716 Reveal Potential Predictive Biomarkers for Tolerability
por: Howard, Faith, et al.
Publicado: (2022) -
The ‘Ins and Outs’ of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong?
por: Rominiyi, Ola, et al.
Publicado: (2019)